After the targets are irradiated they are transported to a Mo-99 processing facility.
Processor Name: MDS NordionLocation: CanadaRelated Reactor: NRUPercent of World Supply: 40%
Processor Name: The Institute for Radio Elements (IRE)Location: BelgiumRelated Reactor: HFR, BR-2, OSIRIS, LVR-15 REZPercent of World Supply: 17%
Processor Name: MallinckrodtLocation: NetherlandsRelated Reactor: HFR, BR-2, MariaPercent of World Supply: 26%
Processor Name: Nuclear Technology Products (NTP)Location: South AfricaRelated Reactor: SAFARI-1Percent of World Supply: 10%
Processor Name: Australian Nuclear Science & Technology Organization (ANSTO)Location: AustraliaRelated Reactor: OPALPercent of World Supply: 3%
Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.
© 2017 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.